Healthcare provider profile · identity verified

Julie E Cahill, MD

Family Practice · SEDALIA, MO · NPI 1104883925

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	566	128
Levothyroxine Sodium	Levothyroxine Sodium	555	104
Lisinopril	Lisinopril	338	72
Amlodipine Besylate	Amlodipine Besylate	334	77
Losartan Potassium	Losartan Potassium	292	73
Metformin Hcl	Metformin Hcl	277	61
Omeprazole	Omeprazole	277	61
Pantoprazole Sodium	Pantoprazole Sodium	236	58
Potassium Chloride	Potassium Chloride	206	49
Gabapentin	Gabapentin	198	41
Metoprolol Succinate	Metoprolol Succinate	193	46
Rosuvastatin Calcium	Rosuvastatin Calcium	188	43
Hydrochlorothiazide	Hydrochlorothiazide	165	40
Sertraline Hcl	Sertraline Hcl	144	24
Furosemide	Furosemide	136	34
Duloxetine Hcl	Duloxetine Hcl	131	17
Carvedilol	Carvedilol	125	23
Ozempic	Semaglutide	125	19
Warfarin Sodium	Warfarin Sodium	123	14
Glipizide	Glipizide	120	26
Metoprolol Tartrate	Metoprolol Tartrate	120	24
Meloxicam	Meloxicam	115	26
Alendronate Sodium	Alendronate Sodium	111	29
Famotidine	Famotidine	109	27
Tramadol Hcl	Tramadol Hcl	105	33
Escitalopram Oxalate	Escitalopram Oxalate	100	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	100	33
Bupropion Xl	Bupropion Hcl	94	17
Zolpidem Tartrate	Zolpidem Tartrate	93	13
Eliquis	Apixaban	92	13
Pregabalin	Pregabalin	88	12
Albuterol Sulfate Hfa	Albuterol Sulfate	87	26
Citalopram Hbr	Citalopram Hydrobromide	87	18
Alprazolam	Alprazolam	85	19
Celecoxib	Celecoxib	84	18
Allopurinol	Allopurinol	76	15
Simvastatin	Simvastatin	76	16
Cefuroxime	Cefuroxime Axetil	69	62
Clonazepam	Clonazepam	68	12
Paroxetine Hcl	Paroxetine Hcl	68	13
Prednisone	Prednisone	66	46
Lorazepam	Lorazepam	63	11
Tamsulosin Hcl	Tamsulosin Hcl	60	13
Mounjaro	Tirzepatide	59	suppressed
Cephalexin	Cephalexin	57	47
Clopidogrel	Clopidogrel Bisulfate	57	14
Estradiol	Estradiol	57	22
Fluticasone Propionate	Fluticasone Propionate	57	21
Ibuprofen	Ibuprofen	57	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	11
Ropinirole Hcl	Ropinirole Hcl	56	suppressed
Fenofibrate	Fenofibrate	55	13
Memantine Hcl	Memantine Hcl	54	suppressed
Jardiance	Empagliflozin	53	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	53	suppressed
Ezetimibe	Ezetimibe	50	11
Methylprednisolone	Methylprednisolone	49	42
Montelukast Sodium	Montelukast Sodium	48	11
Donepezil Hcl	Donepezil Hcl	47	suppressed
Spironolactone	Spironolactone	47	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	46	29
Fluoxetine Hcl	Fluoxetine Hcl	44	11
Pravastatin Sodium	Pravastatin Sodium	44	11
Chlorthalidone	Chlorthalidone	43	13
Januvia	Sitagliptin Phosphate	43	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	41	suppressed
Torsemide	Torsemide	41	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	29
Venlafaxine Hcl Er	Venlafaxine Hcl	40	11
Buspirone Hcl	Buspirone Hcl	39	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	suppressed
Xarelto	Rivaroxaban	38	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Mupirocin	Mupirocin	37	14
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	37	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Invokana	Canagliflozin	36	suppressed
Lovastatin	Lovastatin	36	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	13
Doxycycline Hyclate	Doxycycline Hyclate	34	25
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Azithromycin	Azithromycin	33	27
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	33	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	32	15
Trazodone Hcl	Trazodone Hcl	32	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	suppressed
Diazepam	Diazepam	28	suppressed
Glimepiride	Glimepiride	28	suppressed
Ondansetron Odt	Ondansetron	28	11
Westab Plus	Pnv,calcium 72/Iron/Folic Acid	28	suppressed
Linzess	Linaclotide	27	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	19
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Varenicline Tartrate	Varenicline Tartrate	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Atenolol	Atenolol	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	22	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	21	21
Azelastine Hcl	Azelastine Hcl	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Finasteride	Finasteride	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Risedronate Sodium	Risedronate Sodium	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Acyclovir	Acyclovir	20	12
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	17
Levetiracetam	Levetiracetam	19	suppressed
Fluconazole	Fluconazole	18	13
Glipizide Er	Glipizide	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Premarin	Estrogens, Conjugated	17	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Naproxen	Naproxen	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Nystatin	Nystatin	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Levofloxacin	Levofloxacin	14	12
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Galantamine Hbr	Galantamine Hbr	13	suppressed
Gemtesa	Vibegron	13	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Colestipol Hcl	Colestipol Hcl	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Metformin Er Gastric	Metformin Hcl	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Primidone	Primidone	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Digoxin	Digoxin	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Imipramine Hcl	Imipramine Hcl	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Savella	Milnacipran Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error